Viewing Study NCT03387904


Ignite Creation Date: 2025-12-24 @ 7:59 PM
Ignite Modification Date: 2025-12-30 @ 11:37 AM
Study NCT ID: NCT03387904
Status: UNKNOWN
Last Update Posted: 2021-09-02
First Post: 2017-12-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module